Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Medical Diagnostic Laboratories, L.L.C. v. Protagonist Therapeutics, Inc.
Case Number:
3:17-cv-05572
See also:
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 08, 2018
Safe Harbor Protects Protagonist From Infringement Suit
A reference laboratory can't sue Protagonist Therapeutics for allegedly infringing a patent tied to a potential treatment for autoimmune disorders, as the drug company is protected by a safe harbor tied to developing drugs to be submitted for federal approval, a California federal judge said Wednesday in dismissing the suit.
-
January 19, 2018
Lab's Peptide IP Suit May Run Aground On Safe Harbor
A California federal judge told Medical Diagnostic Laboratories LLC on Friday that he may have to dismiss its patent infringement suit over its proprietary peptides because they were allegedly used by Protagonist Therapeutics Inc. to develop an autoimmune disorder drug for U.S. Food and Drug Administration approval, an activity protected by the safe harbor rule.